23andMe Turns Spit Into Dollars in Deal With Pfizer

Jan 12, 2015, 00:00 AM by Michael Croft

Bloomberg | 23andMe Inc., the genetic-testing startup backed by Google Inc., is sharing DNA data on about 650,000 individuals with Pfizer Inc., to help find new targets to treat disease and to design clinical trials.

January 12, 2015 | 23andMe Inc., the genetic-testing startup backed by Google Inc., is sharing DNA data on about 650,000 individuals with Pfizer Inc., to help find new targets to treat disease and to design clinical trials. Bloomberg